ENDOMETRIOID ENDOMETRIAL CARCINOMA: AN INSTITUTIONAL CASE SERIES
DOI:
https://doi.org/10.22159/ajpcr.2024v17i12.52818Keywords:
Endometrioid endometrial carcinoma, Endometrium, CarcinomaAbstract
Objective: To present a case series of endometrioid endometrial carcinoma having diverse presentations, histopathological features, and therapeutic modalities.
Methods: A case series of five cases of histopathologically diagnosed endometrioid endometrial carcinoma in a tertiary care center has been presented. Cases were collected over a period of 8 months (April 2017–December 2017).
Results: The ages of the patients ranged from 48 to 67 years. All patients were post-menopausal and one patient was pre-menopausal. In histopathology, there were two cases of grade 1, two cases of grade 3, and a single case of grade 2. FIGO staging of the cancers ranged from stage I to stage IIIc and appropriate therapeutic modalities were used based on grading and staging of the malignancies.
Conclusion: This case series highlights the clinical heterogeneity of endometrioid endometrial carcinoma. Increased education regarding early screening measures of endometrial carcinoma will aid in optimizing prevention and treatment protocols.
Downloads
References
Gupta PK, Singh S, Gupta R, Lal P, Rastogi N. A fifteen years audit of endometrial cancer referred for adjuvant treatment to a tertiary Care Hospital in Northern India. J Clin Diagn Res. 2023;17(7):XC01-5. doi: 10.7860/JCDR/2023/63369.18095
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262, PMID: 25651787
Emons G, Beckmann MW, Schmidt D, Mallmann P. New WHO classification of endometrial hyperplasias. Geburtshilfe Frauenheilkd. 2015;75(2):135-6.
Wilczyński M, Danielska J, Wilczyński J. An update of the classical Bokhman’s dualistic model of endometrial cancer. Prz Menopauzalny. 2016;15(2):63-8. doi: 10.5114/pm.2016.61186, PMID: 27582678
Parker LM, Lewin SN, Nasser SM, Webb TD, Gibbons HE, Birrer MJ. Endometrial carcinoma: Clinical challenges and future directions. J Clin Oncol. 2020;38(12):1395-404. doi: 10.1200/ JCO.19.03241
Cohen LW, Fuh KC, Kwon JS, Bristow RE. Outcomes in patients with endometrioid endometrial carcinoma: A review. Gynecol Oncol. 2016;140(2):218-23.
Morris RT, Lim MC, Lee MC, Kim HJ, Kim YB, Kang SB. Neoadjuvant chemotherapy for endometrial cancer: A systematic review. Int J Gynecol Cancer. 2020;30(5):745-53.
Harlan LC, Krapcho M, Stewart SL, Aminou R, Altekruse SF, Ries LA, et al. Risk factors for endometrial cancer: Insights from the SEER database. Cancer Epidemiol Biomarkers Prev. 2018;27(3):329-35.
Raffone A, Corrado G, Maltese G, Leone FA, De Franciscis P. Hereditary cancer syndromes and their association with endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2019;236:29-34.
Fitzgerald CK, Lin KT, Wang HW, Chen YC, Liu CH, Chen TF, et al. Endometrioid carcinoma: Epidemiology, diagnosis, and treatment. Cancer Epidemiol. 2019;58:58-65.
Published
How to Cite
Issue
Section
Copyright (c) 2024 K.T ATHULYA KRISHNA KUMAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
